Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 51

1.

Upregulation of Apoptosis Pathway Genes in Peripheral Blood Mononuclear Cells of HIV-Infected Individuals with Antiretroviral Therapy-Associated Mitochondrial Toxicity.

Foli Y, Ghebremichael M, Li M, Paintsil E.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00522-17. doi: 10.1128/AAC.00522-17. Print 2017 Aug.

PMID:
28584150
2.

Building Sustainable Local Capacity for Global Health Research in West Africa.

Sam-Agudu NA, Paintsil E, Aliyu MH, Kwara A, Ogunsola F, Afrane YA, Onoka C, Awandare GA, Amponsah G, Cornelius LJ, Mendy G, Sturke R, Ghansah A, Siberry GK, Ezeanolue EE.

Ann Glob Health. 2016 Nov - Dec;82(6):1010-1025. doi: 10.1016/j.aogh.2016.10.011.

PMID:
28314488
3.

Impact of HIV-Status Disclosure on Adherence to Antiretroviral Therapy Among HIV-Infected Children in Resource-Limited Settings: A Systematic Review.

Nichols J, Steinmetz A, Paintsil E.

AIDS Behav. 2017 Jan;21(1):59-69. doi: 10.1007/s10461-016-1481-z. Review.

PMID:
27395433
4.

The DNA Polymerase Gamma R953C Mutant Is Associated with Antiretroviral Therapy-Induced Mitochondrial Toxicity.

Li M, Mislak AC, Foli Y, Agbosu E, Bose V, Bhandari S, Szymanski MR, Shumate CK, Yin YW, Anderson KS, Paintsil E.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5608-11. doi: 10.1128/AAC.00976-16. Print 2016 Sep.

5.

Frequent Episodes of Detectable Viremia in HIV Treatment-Experienced Children is Associated with a Decline in CD4+ T-cells Over Time.

Paintsil E, Martin R, Goldenthal A, Bhandari S, Andiman W, Ghebremichael M.

J AIDS Clin Res. 2016 Apr;7(4). pii: 565. doi: 10.4172/2155-6113.1000565. Epub 2016 Apr 14.

6.

High frequency of mitochondrial DNA mutations in HIV-infected treatment-experienced individuals.

Li M, Foli Y, Liu Z, Wang G, Hu Y, Lu Q, Selvaraj S, Lam W, Paintsil E.

HIV Med. 2017 Jan;18(1):45-55. doi: 10.1111/hiv.12390. Epub 2016 Jun 22.

7.

Viral load monitoring and antiretroviral treatment outcomes in a pediatric HIV cohort in Ghana.

Kukoyi O, Renner L, Powell J, Barry O, Prin M, Kusah J, Cong X, Paintsil E.

BMC Infect Dis. 2016 Feb 3;16:58. doi: 10.1186/s12879-016-1402-9.

8.

Correction: Survival of Hepatitis C Virus in Syringes Is Dependent on the Design of the Syringe-Needle and Dead Space Volume.

Binka M, Paintsil E, Patel A, Lindenbach BD, Heimer R.

PLoS One. 2015 Dec 23;10(12):e0146088. doi: 10.1371/journal.pone.0146088. eCollection 2015. No abstract available.

9.

Sankofa pediatric HIV disclosure intervention cyber data management: building capacity in a resource-limited setting and ensuring data quality.

Catlin AC, Fernando S, Gamage R, Renner L, Antwi S, Tettey JK, Amisah KA, Kyriakides T, Cong X, Reynolds NR, Paintsil E.

AIDS Care. 2015;27 Suppl 1:99-107. doi: 10.1080/09540121.2015.1023246.

10.

HIV knowledge, stigma, and illness beliefs among pediatric caregivers in Ghana who have not disclosed their child's HIV status.

Paintsil E, Renner L, Antwi S, Dame J, Enimil A, Ofori-Atta A, Alhassan A, Ofori IP, Cong X, Kyriakides T, Reynolds NR.

AIDS Care. 2015;27 Suppl 1:18-27. doi: 10.1080/09540121.2015.1007116.

11.

Infectious Diseases of Poverty in Children: A Tale of Two Worlds.

Hansen C, Paintsil E.

Pediatr Clin North Am. 2016 Feb;63(1):37-66. doi: 10.1016/j.pcl.2015.08.002. Review.

12.

Survival of Hepatitis C Virus in Syringes Is Dependent on the Design of the Syringe-Needle and Dead Space Volume.

Binka M, Paintsil E, Patel A, Lindenbach BD, Heimer R.

PLoS One. 2015 Nov 4;10(11):e0139737. doi: 10.1371/journal.pone.0139737. eCollection 2015. Erratum in: PLoS One. 2015;10(12):e0146088.

13.

SANKOFA: a multisite collaboration on paediatric HIV disclosure in Ghana.

Reynolds NR, Ofori-Atta A, Lartey M, Renner L, Antwi S, Enimil A, Catlin AC, Fernando S, Kyriakides TC, Paintsil E.

AIDS. 2015 Jun;29 Suppl 1:S35-45. doi: 10.1097/QAD.0000000000000725.

14.

Disinfection of syringes contaminated with hepatitis C virus by rinsing with household products.

Binka M, Paintsil E, Patel A, Lindenbach BD, Heimer R.

Open Forum Infect Dis. 2015 Feb 23;2(1):ofv017. doi: 10.1093/ofid/ofv017. eCollection 2015 Jan.

15.

Antiretroviral therapy-induced toxicity is associated with increased mRNA expression of telomerase.

Li M, Foli Y, Amakye NY, Klein T, Selvaraj S, Lu L, Paintsil E.

J Clin Pharmacol. 2015 Oct;55(10):1119-24. doi: 10.1002/jcph.520. Epub 2015 May 28. No abstract available.

16.

Cost effectiveness of option B plus for prevention of mother-to-child transmission of HIV in resource-limited countries: evidence from Kumasi, Ghana.

VanDeusen A, Paintsil E, Agyarko-Poku T, Long EF.

BMC Infect Dis. 2015 Mar 18;15:130. doi: 10.1186/s12879-015-0859-2.

17.

Association of circulating cytochrome c with clinical manifestations of antiretroviral-induced toxicity.

Langs-Barlow A, Selvaraj S, Ogbuagu O, Shabanova V, Shapiro ED, Paintsil E.

Mitochondrion. 2015 Jan;20:71-4. doi: 10.1016/j.mito.2014.11.004. Epub 2014 Nov 28.

18.

Two Independent HIV Epidemics in Saint Petersburg, Russia Revealed by Molecular Epidemiology.

Dukhovlinova E, Masharsky A, Toussova O, Verevochkin S, Solovyeva T, Meringof M, Paintsil E, White E, Barbour R, Heimer R, Kozlov A.

AIDS Res Hum Retroviruses. 2015 Jun;31(6):608-14. doi: 10.1089/AID.2014.0150. Epub 2015 Jan 5.

19.

Impact of human immunodeficiency virus type-1 sequence diversity on antiretroviral therapy outcomes.

Langs-Barlow A, Paintsil E.

Viruses. 2014 Oct 20;6(10):3855-72. doi: 10.3390/v6103855. Review.

20.

Antiretroviral therapy-induced mitochondrial toxicity: potential mechanisms beyond polymerase-γ inhibition.

Selvaraj S, Ghebremichael M, Li M, Foli Y, Langs-Barlow A, Ogbuagu A, Barakat L, Tubridy E, Edifor R, Lam W, Cheng YC, Paintsil E.

Clin Pharmacol Ther. 2014 Jul;96(1):110-20. doi: 10.1038/clpt.2014.64. Epub 2014 Mar 17.

Supplemental Content

Loading ...
Support Center